Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVEO | AMGN | VRTX | REGN | GSK |
| Company | Aveo Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 14.99 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 15.00 | 315.81 | 447.85 | 987.99 | 45.19 |
| Low | 14.99 | 312.62 | 442.99 | 978.21 | 44.40 |
| Last | 15.00 | 314.54 | 445.87 | 987.27 | 44.59 |
| Change | unch | +2.07 | +0.66 | +4.98 | -0.39 |
| % Change | unch | +0.66% | +0.15% | +0.51% | -0.87% |
| Volume | 247,800 | 1,366,264 | 740,999 | 310,815 | 5,169,742 |
| 20-Day Average Volume | 507,320 | 2,842,438 | 1,075,762 | 446,910 | 3,509,319 |
| Previous Close | 15.00 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 295.60 | 414.77 | 943.57 | 43.46 |
| 20-Day Raw Stochastic | 100.00% | 82.45% | 98.61% | 97.54% | 76.06% |
| 20-Day Relative Strength | 75.60% | 63.81% | 72.81% | 61.95% | 62.92% |
| Weighted Alpha | +144.00 | +41.20 | +36.64 | +35.27 | +33.27 |
| Today's Opinion | 100% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 01/11/23 | +1.35% since 05/13/24 | +3.99% since 05/13/24 | +0.94% since 05/13/24 | -1.15% since 05/13/24 |
| Low | 14.97 on 01/12/23 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 15.00 on 01/19/23 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | +0.60% since 12/19/22 | +16.25% since 04/19/24 | +13.39% since 04/19/24 | +9.96% since 04/19/24 | +12.33% since 04/19/24 |
| Low | 14.90 on 12/20/22 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 15.00 on 01/19/23 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +1.83% since 10/19/22 | +10.27% since 02/20/24 | +6.28% since 02/20/24 | +4.15% since 02/20/24 | +6.26% since 02/20/24 |
| Low | 14.67 on 10/20/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 15.00 on 01/19/23 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +126.93% since 07/19/22 | +17.81% since 11/20/23 | +25.29% since 11/20/23 | +23.02% since 11/20/23 | +27.17% since 11/20/23 |
| Low | 6.61 on 07/20/22 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 15.00 on 01/19/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 521,445 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 34,763 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 42,300,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -53,340,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 30,450,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -3,270,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.00 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 11/07/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 03/13/23 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |